Thomas Andrew Crockett - Net Worth and Insider Trading
Thomas Andrew Crockett Net Worth
The estimated net worth of Thomas Andrew Crockett is at least $3 Million dollars as of 2024-05-04. Thomas Andrew Crockett is the CEO of KalVista Pharmaceuticals Inc and owns about 211,203 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $3 Million. Details can be seen in Thomas Andrew Crockett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas Andrew Crockett has not made any transactions after 2024-02-20 and currently still holds the listed stock(s).
Transaction Summary of Thomas Andrew Crockett
Thomas Andrew Crockett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Andrew Crockett owns 1 companies in total, including KalVista Pharmaceuticals Inc (KALV) .
Click here to see the complete history of Thomas Andrew Crockett’s form 4 insider trades.
Insider Ownership Summary of Thomas Andrew Crockett
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2024-02-20 | director & President and CEO |
Thomas Andrew Crockett Latest Holdings Summary
Thomas Andrew Crockett currently owns a total of 1 stock. Thomas Andrew Crockett owns 211,203 shares of KalVista Pharmaceuticals Inc (KALV) as of February 20, 2024, with a value of $3 Million.
Latest Holdings of Thomas Andrew Crockett
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2024-02-20 | 211,203 | 12.13 | 2,561,892 |
Holding Weightings of Thomas Andrew Crockett
Thomas Andrew Crockett Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Andrew Crockett has made a total of 24 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years, including 0 buys and 24 sells. The most-recent trade in KalVista Pharmaceuticals Inc is the sale of 24,888 shares on February 20, 2024, which brought Thomas Andrew Crockett around $351,170.
Insider Trading History of Thomas Andrew Crockett
- 1
Thomas Andrew Crockett Trading Performance
Thomas Andrew Crockett Ownership Network
Thomas Andrew Crockett Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Thomas Andrew Crockett is the director & President and CEO of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include Chief Scientific Officer Edward P. Feener , Chief Medical Officer Paul K. Audhya , and CFO and Secretary Benjamin L Palleiko .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Thomas Andrew Crockett made 9 insider transaction in KalVista Pharmaceuticals Inc (KALV) with a net sale of 167,039. Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 110,937 shares made by Edward P. Feener , and a net sale of 99,445 shares made by Benjamin L Palleiko .
In summary, during the past 3 months, insiders sold 269,594 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 86,048 shares, with a net sale of 183,546 shares. During the past 18 months, 505,299 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 745,718 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
Thomas Andrew Crockett Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Andrew Crockett. You might contact Thomas Andrew Crockett via mailing address: Building 227, Tetricus Science Park, Porton Down, Salisbury, Wiltshire X0 Sp4 0jq.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
